Exhibition
_2.jpg)
COVID19+9G test(TM)
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- diagnostic kit, covid19
- Category
- Medical Test Kit
Biometrix Technology Co, Ltd
- Country / Year Established
-
South Korea
/
2000
- Business type
- Manufacturer
- Verified Certificate
-
4
| Product name | COVID19+9G test(TM) | Certification | - |
|---|---|---|---|
| Category | Medical Test Kit | Ingredients | - |
| Keyword | diagnostic kit , covid19 | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | - |
| Supply type | - | HS code | - |
Product Information
Why our kit takes unique position in the market? Wondering why our products have caught MOH’s interests from each country? We are proud to inform you that our COVID19+ 9G test™ LoD capacity covers 10 copies per test, and this provides BMT the unparalleled stance in the current diagnostic kit market.
Here are the other features you might want to take a look for our product:
- N gene, ORF3a gene, and RdRp gene are distinct genes identified only in COVID-19.
- E gene is a gene found in other corona family viruses as well.
- LoD of The COVID19+ 9G test™ 10 copies/test.
- LoD of 10 copies/test and 10^2 copies/sample-> not only allows the accurate detection of COVID-19
but also enables this test to detect recurrence earlier.
For much further details/clarifications, kindly reach us and we will be happy to be connected with you.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
Biometrix Technology Co, Ltd
- Country / Year Established
-
South Korea
/
2000
- Business type
- Manufacturer
-
4
- President
- KIM TAE SEON
- Address
- Soyanggangro 56 Bioventureplaza 2 2 ho , Chuncheon-si, Gangwon-do, Korea
- Product Category
- Medical Test Kit,Other Monitoring & Diagnostic Equipment
- Year Established
- 2000
- No. of Total Employees
- 1-50
- Company introduction
-
Biometrix Technology. Inc. has developed the world’s first 9G technology that arranges 9 guanine bases at regular intervals in a molecular recognition format and DAGON technology that can detect marker proteins up to a pg/ml level. Based on this core technology, we have established a platform technology applicable to the detection of various genes and proteins, and based on this, we sell IVD diagnostic devices and reagents. Using this technology, Biometrix Technology has entered into the market for cardiovascular disease prevention and management by using cardiovascular monitoring products to easily manage cardiovascular diseases. In addition, we are working hard to lead the field of early cancer screening molecular diagnostics that no one has entered the market yet. Biometrix Technology continues to showcase the world’s leading cardiovascular and early-stage cancer molecular diagnostic reagents and hopes to become the world’s leading professional healthcare company.
- Main Product
_Cancer_Lung_2.jpg "9G test_TM_ Cancer_Lung_6")
_Test_kit_2.jpg "MTBDR_RIF 9G Membrane Kit_Test kit_2")
_2.jpg "COVID19_9G test_TM__1")
